EUVIMEDObjevte EUVIMED
Open access

A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection

Mohamad-Gabriel Alameh iD, Alexa Semon iD, Nile U Bayard, Yi-Gen Pan iD, Garima Dwivedi, James Knox iD, Rochelle C Glover iD, Paula C Rangel, Ceylan Tanes, Kyle Bittinger iD, Qianxuan She, Haitao Hu iD and 17 more

Science · 2024-10-04 · 386 (6717) · 69-75

DOI: 10.1126/science.adn4955 ↗

At a glance

Journal article in Science, published on 2024-10-04. Written by Mohamad-Gabriel Alameh and 28 co-authors. Institution: Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Major MEDLINE topics: Bacterial Toxins, Bacterial Vaccines, Clostridioides difficile, Clostridium Infections. Cited 90 times so far (Crossref); 69 references. The full text is freely available in PubMed Central. Funded by: NIAID NIH HHS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Clostridioides difficile infection (CDI) is an urgent public health threat with limited preventative options. In this work, we developed a messenger RNA (mRNA)–lipid nanoparticle (LNP) vaccine targeting C. difficile toxins and virulence factors. This multivalent vaccine elicited robust and long-lived systemic and mucosal antigen-specific humoral and cellular immune responses across animal models, independent of changes to the intestinal microbiota. Vaccination protected mice from lethal CDI in both primary and recurrent infection models, and inclusion of non-toxin cellular and spore antigens improved decolonization of toxigenic C. difficile from the gastrointestinal tract. Our studies demonstrate mRNA-LNP vaccine technology as a promising platform for the development of novel C. difficile therapeutics with potential for limiting acute disease and promoting bacterial decolonization.

Subjects

MeSH terms (MEDLINE)

Bacterial ToxinsBacterial VaccinesClostridioides difficileClostridium InfectionsmRNA VaccinesNanoparticlesVaccines, CombinedAnimalsFemaleMiceBacterial ProteinsDisease Models, AnimalGastrointestinal MicrobiomeImmunity, CellularImmunity, HumoralLiposomesMice, Inbred C57BLRNA, MessengerVirulence Factors

Substances

Bacterial ProteinsBacterial ToxinsBacterial VaccinesLipid NanoparticlesLiposomesmRNA VaccinesRNA, MessengerVirulence FactorsVaccines, Combined

Authors and institutions

  • Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Penn Institute for RNA Innovation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Division of Infectious Disease, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

ORCID profiles: Mohamad-Gabriel Alameh, Alexa Semon, Yi-Gen Pan, James Knox, Rochelle C Glover, Kyle Bittinger, Haitao Hu, Srinivasa Reddy Bonam, Jeffrey R Maslanka, Paul J Planet, Ahmed M Moustafa, Benjamin Davis, Anik Chevrier, Mitchell Beattie, Robert H Mach, Marc Lavertu, Mark A Sellmyer, Ying Tam, Michael C Abt, Drew Weissman, Joseph P Zackular

Funding

  • NIAID NIH HHS

Cite

APA

Alameh, M. G., Semon, A., Bayard, N. U., Pan, Y. G., Dwivedi, G., Knox, J., Glover, R. C., Rangel, P. C., Tanes, C., Bittinger, K., She, Q., Hu, H., Bonam, S. R., Maslanka, J. R., Planet, P. J., Moustafa, A. M., Davis, B., Chevrier, A., Beattie, M., …, & Zackular, J. P. (2024). A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection. Science, 386(6717), 69-75. https://doi.org/10.1126/science.adn4955

Vancouver

Alameh MG, Semon A, Bayard NU, Pan YG, Dwivedi G, Knox J, et al. A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection. Science. 2024;386(6717):69-75. doi:10.1126/science.adn4955

BibTeX
@article{Alameh2024,
  author = {Alameh, Mohamad-Gabriel and Semon, Alexa and Bayard, Nile U and Pan, Yi-Gen and Dwivedi, Garima and Knox, James and Glover, Rochelle C and Rangel, Paula C and Tanes, Ceylan and Bittinger, Kyle and She, Qianxuan and Hu, Haitao and Bonam, Srinivasa Reddy and Maslanka, Jeffrey R and Planet, Paul J and Moustafa, Ahmed M and Davis, Benjamin and Chevrier, Anik and Beattie, Mitchell and Ni, Houping and Blizard, Gabrielle and Furth, Emma E and Mach, Robert H and Lavertu, Marc and Sellmyer, Mark A and Tam, Ying and Abt, Michael C and Weissman, Drew and Zackular, Joseph P},
  title = {A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection},
  journal = {Science},
  year = {2024},
  volume = {386},
  number = {6717},
  pages = {69--75},
  doi = {10.1126/science.adn4955}
}
Start for free →